Reading Time: < 1 minute
The Europe blood screening market size is expected to reach USD 1.17 billion by 2025 according to a new report by Grand View Research, Inc. The market is expected to record a CAGR of 7.7% during the forecast period. Increasing number of blood transfusion processes performed along with stringent regulations in Europe mandating screening tests, such as NAT for testing HIV, HBV, and HCV, is contributing to the market growth. Read More